Global and United States Kidney Cancer Market Size, Status and Forecast 2020-2026

SKU ID : QYR-16338381 | Publishing Date : 01-Sep-2020 | No. of pages : 94

Request Sample

Pre-order Enquiry

Request Customization

Check Discounts

Request a free Sample

Detailed TOC of Global and United States Kidney Cancer Market Size, Status and Forecast 2020-2026

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Kidney Cancer Market Size Growth Rate by Type: 2020 VS 2026
        1.2.2 Renal Cell Carcinoma (RCC)
        1.2.3 Transitional Cell Carcinoma (TCC)
    1.3 Market by Application
        1.3.1 Global Kidney Cancer Market Share by Application: 2020 VS 2026
        1.3.2 Surgery
        1.3.3 Immunotherapy
        1.3.4 Chemotherapy
        1.3.5 Radiation Therapy
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Kidney Cancer Market Perspective (2015-2026)
    2.2 Global Kidney Cancer Growth Trends by Regions
        2.2.1 Kidney Cancer Market Size by Regions: 2015 VS 2020 VS 2026
        2.2.2 Kidney Cancer Historic Market Share by Regions (2015-2020)
        2.2.3 Kidney Cancer Forecasted Market Size by Regions (2021-2026)
    2.3 Industry Trends and Growth Strategy
        2.3.1 Market Trends
        2.3.2 Market Drivers
        2.3.3 Market Challenges
        2.3.4 Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Kidney Cancer Players by Market Size
        3.1.1 Global Top Kidney Cancer Players by Revenue (2015-2020)
        3.1.2 Global Kidney Cancer Revenue Market Share by Players (2015-2020)
    3.2 Global Kidney Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Kidney Cancer Revenue
    3.4 Global Kidney Cancer Market Concentration Ratio
        3.4.1 Global Kidney Cancer Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Revenue in 2019
    3.5 Key Players Kidney Cancer Area Served
    3.6 Key Players Kidney Cancer Product Solution and Service
    3.7 Date of Enter into Kidney Cancer Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney Cancer Breakdown Data by Type (2015-2026)
    4.1 Global Kidney Cancer Historic Market Size by Type (2015-2020)
    4.2 Global Kidney Cancer Forecasted Market Size by Type (2021-2026)

5 Kidney Cancer Breakdown Data by Application (2015-2026)
    5.1 Global Kidney Cancer Historic Market Size by Application (2015-2020)
    5.2 Global Kidney Cancer Forecasted Market Size by Application (2021-2026)

6 North America
    6.1 North America Kidney Cancer Market Size (2015-2026)
    6.2 North America Kidney Cancer Market Size by Type (2015-2020)
    6.3 North America Kidney Cancer Market Size by Application (2015-2020)
    6.4 North America Kidney Cancer Market Size by Country (2015-2020)
        6.4.1 United States
        6.4.2 Canada

7 Europe
    7.1 Europe Kidney Cancer Market Size (2015-2026)
    7.2 Europe Kidney Cancer Market Size by Type (2015-2020)
    7.3 Europe Kidney Cancer Market Size by Application (2015-2020)
    7.4 Europe Kidney Cancer Market Size by Country (2015-2020)
        7.4.1 Germany
        7.4.2 France
        7.4.3 U.K.
        7.4.4 Italy
        7.4.5 Russia
        7.4.6 Nordic
        7.4.7 Rest of Europe

8 China
    8.1 China Kidney Cancer Market Size (2015-2026)
    8.2 China Kidney Cancer Market Size by Type (2015-2020)
    8.3 China Kidney Cancer Market Size by Application (2015-2020)
    8.4 China Kidney Cancer Market Size by Region (2015-2020)
        8.4.1 China
        8.4.2 Japan
        8.4.3 South Korea
        8.4.4 Southeast Asia
        8.4.5 India
        8.4.6 Australia
        8.4.7 Rest of Asia-Pacific

9 Japan
    9.1 Japan Kidney Cancer Market Size (2015-2026)
    9.2 Japan Kidney Cancer Market Size by Type (2015-2020)
    9.3 Japan Kidney Cancer Market Size by Application (2015-2020)
    9.4 Japan Kidney Cancer Market Size by Country (2015-2020)
        9.4.1 Mexico
        9.4.2 Brazil

10 Southeast Asia
    10.1 Southeast Asia Kidney Cancer Market Size (2015-2026)
    10.2 Southeast Asia Kidney Cancer Market Size by Type (2015-2020)
    10.3 Southeast Asia Kidney Cancer Market Size by Application (2015-2020)
    10.4 Southeast Asia Kidney Cancer Market Size by Country (2015-2020)
        10.4.1 Turkey
        10.4.2 Saudi Arabia
        10.4.3 UAE
        10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Details
        11.1.2 Merck Business Overview
        11.1.3 Merck Kidney Cancer Introduction
        11.1.4 Merck Revenue in Kidney Cancer Business (2015-2020))
        11.1.5 Merck Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Kidney Cancer Introduction
        11.2.4 Novartis Revenue in Kidney Cancer Business (2015-2020)
        11.2.5 Novartis Recent Development
    11.3 AstraZeneca
        11.3.1 AstraZeneca Company Details
        11.3.2 AstraZeneca Business Overview
        11.3.3 AstraZeneca Kidney Cancer Introduction
        11.3.4 AstraZeneca Revenue in Kidney Cancer Business (2015-2020)
        11.3.5 AstraZeneca Recent Development
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Details
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb Kidney Cancer Introduction
        11.4.4 Bristol-Myers Squibb Revenue in Kidney Cancer Business (2015-2020)
        11.4.5 Bristol-Myers Squibb Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Kidney Cancer Introduction
        11.5.4 Pfizer Revenue in Kidney Cancer Business (2015-2020)
        11.5.5 Pfizer Recent Development
    11.6 Roche
        11.6.1 Roche Company Details
        11.6.2 Roche Business Overview
        11.6.3 Roche Kidney Cancer Introduction
        11.6.4 Roche Revenue in Kidney Cancer Business (2015-2020)
        11.6.5 Roche Recent Development
    11.7 Amgen
        11.7.1 Amgen Company Details
        11.7.2 Amgen Business Overview
        11.7.3 Amgen Kidney Cancer Introduction
        11.7.4 Amgen Revenue in Kidney Cancer Business (2015-2020)
        11.7.5 Amgen Recent Development
    11.8 Argos Therapeutics
        11.8.1 Argos Therapeutics Company Details
        11.8.2 Argos Therapeutics Business Overview
        11.8.3 Argos Therapeutics Kidney Cancer Introduction
        11.8.4 Argos Therapeutics Revenue in Kidney Cancer Business (2015-2020)
        11.8.5 Argos Therapeutics Recent Development
    11.9 Aveo Pharmaceuticals
        11.9.1 Aveo Pharmaceuticals Company Details
        11.9.2 Aveo Pharmaceuticals Business Overview
        11.9.3 Aveo Pharmaceuticals Kidney Cancer Introduction
        11.9.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2015-2020)
        11.9.5 Aveo Pharmaceuticals Recent Development
    11.10 Bayer
        11.10.1 Bayer Company Details
        11.10.2 Bayer Business Overview
        11.10.3 Bayer Kidney Cancer Introduction
        11.10.4 Bayer Revenue in Kidney Cancer Business (2015-2020)
        11.10.5 Bayer Recent Development
    11.11 Exelixis
        10.11.1 Exelixis Company Details
        10.11.2 Exelixis Business Overview
        10.11.3 Exelixis Kidney Cancer Introduction
        10.11.4 Exelixis Revenue in Kidney Cancer Business (2015-2020)
        10.11.5 Exelixis Recent Development
    11.12 Incyte
        10.12.1 Incyte Company Details
        10.12.2 Incyte Business Overview
        10.12.3 Incyte Kidney Cancer Introduction
        10.12.4 Incyte Revenue in Kidney Cancer Business (2015-2020)
        10.12.5 Incyte Recent Development
    11.13 Allergan
        10.13.1 Allergan Company Details
        10.13.2 Allergan Business Overview
        10.13.3 Allergan Kidney Cancer Introduction
        10.13.4 Allergan Revenue in Kidney Cancer Business (2015-2020)
        10.13.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global and United States Kidney Cancer Market Size, Status and Forecast 2020-2026

List of Tables
    Table 1. Global Kidney Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
    Table 3. Key Players of Renal Cell Carcinoma (RCC)
    Table 4. Key Players of Transitional Cell Carcinoma (TCC)
    Table 5. Global Kidney Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
    Table 6. Global Kidney Cancer Market Size by Regions (US$ Million): 2020 VS 2026
    Table 7. Global Kidney Cancer Market Size by Regions (2015-2020) (US$ Million)
    Table 8. Global Kidney Cancer Market Share by Regions (2015-2020)
    Table 9. Global Kidney Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
    Table 10. Global Kidney Cancer Market Share by Regions (2021-2026)
    Table 11. Kidney Cancer Market Market Trends
    Table 12. Kidney Cancer Market Drivers
    Table 13. Kidney Cancer Market Challenges
    Table 14. Kidney Cancer Market Restraints
    Table 15. Global Kidney Cancer Revenue by Players (2015-2020) (US$ Million)
    Table 16. Global Kidney Cancer Market Share by Players (2015-2020)
    Table 17. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer as of 2019)
    Table 18. Global Kidney Cancer by Players Market Concentration Ratio (CR5 and HHI)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Kidney Cancer Product Solution and Service
    Table 21. Mergers & Acquisitions, Expansion Plans
    Table 22. Global Kidney Cancer Market Size by Type (2015-2020) (US$ Million)
    Table 23. Global Kidney Cancer Market Size Share by Type (2015-2020)
    Table 24. Global Kidney Cancer Revenue Market Share by Type (2021-2026)
    Table 25. Global Kidney Cancer Market Size Share by Application (2015-2020)
    Table 26. Global Kidney Cancer Market Size by Application (2015-2020) (US$ Million)
    Table 27. Global Kidney Cancer Market Size Share by Application (2021-2026)
    Table 28. North America Kidney Cancer Market Size by Type (2015-2020) (US$ Million)
    Table 29. North America Kidney Cancer Market Share by Type (2015-2020)
    Table 30. North America Kidney Cancer Market Size by Application (2015-2020) (US$ Million)
    Table 31. North America Kidney Cancer Market Share by Application (2015-2020)
    Table 32. North America Kidney Cancer Market Size by Country (US$ Million) (2015-2020)
    Table 33. North America Kidney Cancer Market Share by Country (2015-2020)
    Table 34. Europe Kidney Cancer Market Size by Type (2015-2020) (US$ Million)
    Table 35. Europe Kidney Cancer Market Share by Type (2015-2020)
    Table 36. Europe Kidney Cancer Market Size by Application (2015-2020) (US$ Million)
    Table 37. Europe Kidney Cancer Market Share by Application (2015-2020)
    Table 38. Europe Kidney Cancer Market Size by Country (US$ Million) (2015-2020)
    Table 39. Europe Kidney Cancer Market Share by Country (2015-2020)
    Table 40. China Kidney Cancer Market Size by Type (2015-2020) (US$ Million)
    Table 41. China Kidney Cancer Market Share by Type (2015-2020)
    Table 42. China Kidney Cancer Market Size by Application (2015-2020) (US$ Million)
    Table 43. China Kidney Cancer Market Share by Application (2015-2020)
    Table 44. China Kidney Cancer Market Size by Region (US$ Million) (2015-2020)
    Table 45. China Kidney Cancer Market Share by Region (2015-2020)
    Table 46. Japan Kidney Cancer Market Size by Type (2015-2020) (US$ Million)
    Table 47. Japan Kidney Cancer Market Share by Type (2015-2020)
    Table 48. Japan Kidney Cancer Market Size by Application (2015-2020) (US$ Million)
    Table 49. Japan Kidney Cancer Market Share by Application (2015-2020)
    Table 50. Japan Kidney Cancer Market Size by Country (US$ Million) (2015-2020)
    Table 51. Japan Kidney Cancer Market Share by Country (2015-2020)
    Table 52. Southeast Asia Kidney Cancer Market Size by Type (2015-2020) (US$ Million)
    Table 53. Southeast Asia Kidney Cancer Market Share by Type (2015-2020)
    Table 54. Southeast Asia Kidney Cancer Market Size by Application (2015-2020) (US$ Million)
    Table 55. Southeast Asia Kidney Cancer Market Share by Application (2015-2020)
    Table 56. Southeast Asia Kidney Cancer Market Size by Country (US$ Million) (2015-2020)
    Table 57. Southeast Asia Kidney Cancer Market Share by Country (2015-2020)
    Table 58. Merck Company Details
    Table 59. Merck Business Overview
    Table 60. Merck Product
    Table 61. Merck Revenue in Kidney Cancer Business (2015-2020) (US$ Million)
    Table 62. Merck Recent Development
    Table 63. Novartis Company Details
    Table 64. Novartis Business Overview
    Table 65. Novartis Product
    Table 66. Novartis Revenue in Kidney Cancer Business (2015-2020) (US$ Million)
    Table 67. Novartis Recent Development
    Table 68. AstraZeneca Company Details
    Table 69. AstraZeneca Business Overview
    Table 70. AstraZeneca Product
    Table 71. AstraZeneca Revenue in Kidney Cancer Business (2015-2020) (US$ Million)
    Table 72. AstraZeneca Recent Development
    Table 73. Bristol-Myers Squibb Company Details
    Table 74. Bristol-Myers Squibb Business Overview
    Table 75. Bristol-Myers Squibb Product
    Table 76. Bristol-Myers Squibb Revenue in Kidney Cancer Business (2015-2020) (US$ Million)
    Table 77. Bristol-Myers Squibb Recent Development
    Table 78. Pfizer Company Details
    Table 79. Pfizer Business Overview
    Table 80. Pfizer Product
    Table 81. Pfizer Revenue in Kidney Cancer Business (2015-2020) (US$ Million)
    Table 82. Pfizer Recent Development
    Table 83. Roche Company Details
    Table 84. Roche Business Overview
    Table 85. Roche Product
    Table 86. Roche Revenue in Kidney Cancer Business (2015-2020) (US$ Million)
    Table 87. Roche Recent Development
    Table 88. Amgen Company Details
    Table 89. Amgen Business Overview
    Table 90. Amgen Product
    Table 91. Amgen Revenue in Kidney Cancer Business (2015-2020) (US$ Million)
    Table 92. Amgen Recent Development
    Table 93. Argos Therapeutics Business Overview
    Table 94. Argos Therapeutics Product
    Table 95. Argos Therapeutics Company Details
    Table 96. Argos Therapeutics Revenue in Kidney Cancer Business (2015-2020) (US$ Million)
    Table 97. Argos Therapeutics Recent Development
    Table 98. Aveo Pharmaceuticals Company Details
    Table 99. Aveo Pharmaceuticals Business Overview
    Table 100. Aveo Pharmaceuticals Product
    Table 101. Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2015-2020) (US$ Million)
    Table 102. Aveo Pharmaceuticals Recent Development
    Table 103. Bayer Company Details
    Table 104. Bayer Business Overview
    Table 105. Bayer Product
    Table 106. Bayer Revenue in Kidney Cancer Business (2015-2020) (US$ Million)
    Table 107. Bayer Recent Development
    Table 108. Exelixis Company Details
    Table 109. Exelixis Business Overview
    Table 110. Exelixis Product
    Table 111. Exelixis Revenue in Kidney Cancer Business (2015-2020) (US$ Million)
    Table 112. Exelixis Recent Development
    Table 113. Incyte Company Details
    Table 114. Incyte Business Overview
    Table 115. Incyte Product
    Table 116. Incyte Revenue in Kidney Cancer Business (2015-2020) (US$ Million)
    Table 117. Incyte Recent Development
    Table 118. Allergan Company Details
    Table 119. Allergan Business Overview
    Table 120. Allergan Product
    Table 121. Allergan Revenue in Kidney Cancer Business (2015-2020) (US$ Million)
    Table 122. Allergan Recent Development
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Kidney Cancer Market Share by Type: 2020 VS 2026
    Figure 2. Renal Cell Carcinoma (RCC) Features
    Figure 3. Transitional Cell Carcinoma (TCC) Features
    Figure 4. Global Kidney Cancer Market Share by Application: 2020 VS 2026
    Figure 5. Surgery Case Studies
    Figure 6. Immunotherapy Case Studies
    Figure 7. Chemotherapy Case Studies
    Figure 8. Radiation Therapy Case Studies
    Figure 9. Kidney Cancer Report Years Considered
    Figure 10. Global Kidney Cancer Market Size (US$ Million), YoY Growth 2015-2026
    Figure 11. Global Kidney Cancer Market Share by Regions: 2020 VS 2026
    Figure 12. Global Kidney Cancer Market Share by Regions (2021-2026)
    Figure 13. Global Kidney Cancer Market Share by Players in 2019
    Figure 14. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer as of 2019
    Figure 15. The Top 10 and 5 Players Market Share by Kidney Cancer Revenue in 2019
    Figure 16. North America Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 17. United States Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 18. Canada Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 19. Europe Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 20. Germany Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 21. France Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 22. U.K. Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 23. Italy Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 24. Russia Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 25. Nordic Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 26. Rest of Europe Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 27. Asia-Pacific Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 28. China Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 29. Japan Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 30. South Korea Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 31. Southeast Asia Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 32. India Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 33. Australia Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 34. Rest of Asia-Pacific Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 35. Latin America Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 36. Mexico Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 37. Brazil Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 38. Middle East & Africa Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 39. Turkey Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 40. Saudi Arabia Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 41. UAE Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 42. Rest of Middle East & Africa Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 43. Merck Revenue Growth Rate in Kidney Cancer Business (2015-2020)
    Figure 44. Novartis Revenue Growth Rate in Kidney Cancer Business (2015-2020)
    Figure 45. AstraZeneca Revenue Growth Rate in Kidney Cancer Business (2015-2020)
    Figure 46. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Business (2015-2020)
    Figure 47. Pfizer Revenue Growth Rate in Kidney Cancer Business (2015-2020)
    Figure 48. Roche Revenue Growth Rate in Kidney Cancer Business (2015-2020)
    Figure 49. Amgen Revenue Growth Rate in Kidney Cancer Business (2015-2020)
    Figure 50. Argos Therapeutics Revenue Growth Rate in Kidney Cancer Business (2015-2020)
    Figure 51. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Business (2015-2020)
    Figure 52. Bayer Revenue Growth Rate in Kidney Cancer Business (2015-2020)
    Figure 53. Exelixis Revenue Growth Rate in Kidney Cancer Business (2015-2020)
    Figure 54. Incyte Revenue Growth Rate in Kidney Cancer Business (2015-2020)
    Figure 55. Allergan Revenue Growth Rate in Kidney Cancer Business (2015-2020)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed

Keyplayers in Global and United States Kidney Cancer Market Size, Status and Forecast 2020-2026

Merck
Novartis
AstraZeneca
Bristol-Myers Squibb
Pfizer
Roche
Amgen
Argos Therapeutics
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Allergan

Global and United States Kidney Cancer Market Size, Status and Forecast 2020-2026

Detailed TOC of Global and United States Kidney Cancer Market Size, Status and Forecast 2020-2026

List of Figures, Tables and Charts Available in Global and United States Kidney Cancer Market Size, Status and Forecast 2020-2026

Keyplayers in Global and United States Kidney Cancer Market Size, Status and Forecast 2020-2026

REQUEST SUMMARY

Our Clients